{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T22:15:11Z","timestamp":1774476911396,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001700","name":"the Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["MEXT"],"award-info":[{"award-number":["MEXT"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"the Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["16K09820"],"award-info":[{"award-number":["16K09820"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["AMED"],"award-info":[{"award-number":["AMED"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["16ek0109043h0003"],"award-info":[{"award-number":["16ek0109043h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Japanese Ministry of Health, Labor, and Welfare","award":["MHLW"],"award-info":[{"award-number":["MHLW"]}]},{"name":"the Japanese Ministry of Health, Labor, and Welfare","award":["21FC1008"],"award-info":[{"award-number":["21FC1008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12185-024-03807-y","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T14:02:17Z","timestamp":1718805737000},"page":"472-481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Detection of factor XIII inhibitors in 33 patients with autoimmune factor XIII deficiency in Japan"],"prefix":"10.1007","volume":"120","author":[{"given":"Masayoshi","family":"Souri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3807-5628","authenticated-orcid":false,"given":"Akitada","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"3807_CR1","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/j.1538-7836.2005.01213.x","volume":"3","author":"L Lorand","year":"2005","unstructured":"Lorand L. Factor XIII and the clotting of fibrinogen: from basic research to medicine. J Thromb Haemost. 2005;3:1337\u201348.","journal-title":"J Thromb Haemost"},{"key":"3807_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1152\/physrev.00016.2010","volume":"91","author":"L Muszbek","year":"2011","unstructured":"Muszbek L, Bereczky Z, Bagoly Z, Kom\u00e1romi I, Katona \u00c9. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev. 2011;91:931\u201372.","journal-title":"Physiol Rev"},{"key":"3807_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12185-012-1064-3","volume":"95","author":"A Ichinose","year":"2012","unstructured":"Ichinose A. Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control. Int J Hematol. 2012;95:362\u201370.","journal-title":"Int J Hematol"},{"key":"3807_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0036-1571341","volume":"42","author":"V Schroeder","year":"2016","unstructured":"Schroeder V, Kohler HP. Factor XIII: structure and function. Semin Thromb Hemost. 2016;42:422\u20138.","journal-title":"Semin Thromb Hemost"},{"key":"3807_CR5","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.3390\/ijms22063055","volume":"22","author":"FSM Alshehri","year":"2021","unstructured":"Alshehri FSM, Whyte CS, Mutch NJ. Factor XIII-A: an indispensable \u201cfactor\u201d in haemostasis and wound healing. Int J Mol Sci. 2021;22:3055.","journal-title":"Int J Mol Sci"},{"key":"3807_CR6","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1111\/hae.13233","volume":"23","author":"V Iva\u0161kevi\u010dius","year":"2017","unstructured":"Iva\u0161kevi\u010dius V, Biswas A, Garly ML, Oldenburg J. Comparison of F13A1 gene mutations in 73 patients treated with recombinant FXIII-A2. Haemophilia. 2017;23:e194\u2013203.","journal-title":"Haemophilia"},{"key":"3807_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257322","volume":"16","author":"T Osaki","year":"2021","unstructured":"Osaki T, Souri M, Ichinose A. Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis. PLoS ONE. 2021;16: e0257322.","journal-title":"PLoS ONE"},{"key":"3807_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s12185-022-03301-3","volume":"115","author":"T Osaki","year":"2022","unstructured":"Osaki T, Souri M, Ichinose A. Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development. Int J Hematol. 2022;115:672\u201385.","journal-title":"Int J Hematol"},{"key":"3807_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11239-012-0818-3","volume":"36","author":"M Franchini","year":"2013","unstructured":"Franchini M, Frattini F, Crestani S, Bonfanti C. Acquired FXIII inhibitors: a systematic review. J Thromb Thrombolysis. 2013;36:109\u201314.","journal-title":"J Thromb Thrombolysis"},{"key":"3807_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.blre.2016.08.002","volume":"31","author":"A Ichinose","year":"2017","unstructured":"Ichinose A, Japanese Collaborative Research Group on AH13. Autoimmune acquired factor XIII deficiency due to anti-factor XIII\/13 antibodies: a summary of 93 patients. Blood Rev. 2017;31:37\u201345.","journal-title":"Blood Rev"},{"key":"3807_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tmrv.2016.04.001","volume":"30","author":"KJ Tone","year":"2016","unstructured":"Tone KJ, James TE, Fergusson DA, et al. Acquired factor XIII inhibitor in hospitalized and perioperative patients: a systematic review of case reports and case series. Transfus Med Rev. 2016;30:123\u201331.","journal-title":"Transfus Med Rev"},{"key":"3807_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/jth.13982","volume":"16","author":"L Muszbek","year":"2018","unstructured":"Muszbek L, P\u00e9nzes K, Katona \u00c9. Auto- and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences. J Thromb Haemost. 2018;16:822\u201332.","journal-title":"J Thromb Haemost"},{"key":"3807_CR13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/hae.14298","volume":"27","author":"A Ichinose","year":"2021","unstructured":"Ichinose A, Osaki T, Souri M. Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti-factor XIII autoantibodies. Haemophilia. 2021;27:454\u201362.","journal-title":"Haemophilia"},{"key":"3807_CR14","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1111\/hae.14613","volume":"28","author":"A Ichinose","year":"2022","unstructured":"Ichinose A, Osaki T, Souri M. Autoimmune acquired factor XIII deficiency in Japan 2021 update: focused on annual incidence and clinical features. Haemophilia. 2022;28:e121\u20134.","journal-title":"Haemophilia"},{"key":"3807_CR15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1182\/blood-2008-09-179333","volume":"113","author":"E Ajzner","year":"2009","unstructured":"Ajzner E, Schlammadinger A, Ker\u00e9nyi A, et al. Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood. 2009;113:723\u20135.","journal-title":"Blood"},{"key":"3807_CR16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/jth.12877","volume":"13","author":"M Souri","year":"2015","unstructured":"Souri M, Osaki T, Ichinose A. Anti-factor XIII A subunit (FXIII-A) autoantibodies block FXIII-A2B2 assembly and steal FXIII-A from native FXIII-A2B2. J Thromb Haemost. 2015;13:802\u201314.","journal-title":"J Thromb Haemost"},{"key":"3807_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jtha.2022.11.019","volume":"21","author":"M Souri","year":"2023","unstructured":"Souri M, Ozawa T, Osaki T, Koyama T, Muraguchi A, Ichinose A. Cloning of human anti-factor XIII monoclonal antibody dissects mechanisms of polyclonal antibodies in a single patient. J Thromb Haemost. 2023;21:255\u201368.","journal-title":"J Thromb Haemost"},{"key":"3807_CR18","first-page":"2110","volume":"56","author":"A Ichinose","year":"2015","unstructured":"Ichinose A. Diagnosis and treatment of acquired factor XIII\/13 deficiencies: for all doctors treating the MHLW\u2019s designated intractable diseases. Rinsho Ketsueki. 2015;56:2110\u201322.","journal-title":"Rinsho Ketsueki"},{"key":"3807_CR19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/hae.12677","volume":"21","author":"A Ichinose","year":"2015","unstructured":"Ichinose A, Osaki T, Souri M, Japanese Collaborative Research Group (JCRG) on AH13 (supported by the Japanese Ministry of Health, Labor, and Welfare). Clinical features of 32 new Japanese cases with autoimmune hemorrhaphilia due to anti-factor XIII antibodies. Haemophilia. 2015;21:653\u20138.","journal-title":"Haemophilia"},{"key":"3807_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1160\/TH16-05-0362","volume":"116","author":"A Ichinose","year":"2016","unstructured":"Ichinose A, Kohler HP, Philippou H, Factor XIII and Fibrinogen SSC Subcommittee of the ISTH. Recommendation for ISTH\/SSC Criterion 2015 for autoimmune acquired factor XIII\/13 deficiency. Thromb Haemost. 2016;116:772\u20134.","journal-title":"Thromb Haemost"},{"key":"3807_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.2491\/jjsth.26.658","volume":"26","author":"A Ichinose","year":"2015","unstructured":"Ichinose A, Wada H, Souri M, et al. Guidance on diagnostic criteria for autoimmune hemorrhaphilia FXIII\/13 (AHFXIII\/13). Jap J Thromb Hemost. 2015;26:658\u201368.","journal-title":"Jap J Thromb Hemost"},{"key":"3807_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2491\/jjsth.28.393","volume":"28","author":"A Ichinose","year":"2017","unstructured":"Ichinose A, Wada H, Souri M, et al. Guidance on diagnosis and management of autoimmune hemorrhaphilia FXIII\/13 (AHFXIII\/13). Jap J Thromb Hemost. 2017;28:393\u2013420.","journal-title":"Jap J Thromb Hemost"},{"key":"3807_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1172\/JCI109671","volume":"65","author":"Y Sakata","year":"1980","unstructured":"Sakata Y, Aoki N. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest. 1980;65:290\u20137.","journal-title":"J Clin Invest"},{"key":"3807_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0005-2744(81)90016-4","volume":"661","author":"T Tamaki","year":"1981","unstructured":"Tamaki T, Aoki N. Cross-linking of alpha 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor. Biochim Biophys Acta. 1981;661:280\u20136.","journal-title":"Biochim Biophys Acta"},{"key":"3807_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1749-6632.2001.tb03520.x","volume":"936","author":"KN Lee","year":"2001","unstructured":"Lee KN, Lee CS, Tae WC, Jackson KW, Christiansen VJ, McKee PA. Crosslinking of alpha 2-antiplasmin to fibrin. Ann N Y Acad Sci. 2001;936:335\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"3807_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12185-011-0992-7","volume":"95","author":"A Ichinose","year":"2012","unstructured":"Ichinose A, Souri M. Reduced difference of \u03b12-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to anti-factor XIII antibodies. Int J Hematol. 2012;95:47\u201350.","journal-title":"Int J Hematol"},{"key":"3807_CR27","doi-asserted-by":"publisher","first-page":"14767","DOI":"10.1016\/S0021-9258(18)33346-5","volume":"257","author":"T Tamaki","year":"1982","unstructured":"Tamaki T, Aoki N. Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor. J Biol Chem. 1982;257:14767.","journal-title":"J Biol Chem"},{"key":"3807_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0014-5793(83)80645-0","volume":"153","author":"A Ichinose","year":"1983","unstructured":"Ichinose A, Tamaki T, Aoki N. Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin. FEBS Lett. 1983;153:369\u201371.","journal-title":"FEBS Lett"},{"key":"3807_CR29","doi-asserted-by":"publisher","first-page":"37382","DOI":"10.1074\/jbc.M003375200","volume":"275","author":"KN Lee","year":"2000","unstructured":"Lee KN, Lee CS, Tae WC, Jackson KW, Christiansen VJ, McKee PA. Cross-linking of wild-type and mutant alpha 2-antiplasmins to fibrin by activated factor XIII and by a tissue transglutaminase. J Biol Chem. 2000;275:37382\u20139.","journal-title":"J Biol Chem"},{"key":"3807_CR30","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.bbapap.2006.05.003","volume":"1764","author":"DB Cleary","year":"2006","unstructured":"Cleary DB, Maurer MC. Characterizing the specificity of activated Factor XIII for glutamine-containing substrate peptides. Biochim Biophys Acta. 2006;1764:1207\u201317.","journal-title":"Biochim Biophys Acta"},{"key":"3807_CR31","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/clinchem\/34.5.906","volume":"34","author":"KN Lee","year":"1988","unstructured":"Lee KN, Birckbichler PJ, Patterson MK Jr. Colorimetric assay of blood coagulation factor XIII in plasma. Clin Chem. 1988;34:906\u201310.","journal-title":"Clin Chem"},{"key":"3807_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/0003-2697(92)90594-W","volume":"205","author":"TF Slaughter","year":"1992","unstructured":"Slaughter TF, Achyuthan KE, Lai TS, Greenberg CS. A microtiter plate transglutaminase assay utilizing 5-(biotinamido)pentylamine as substrate. Anal Biochem. 1992;205:166\u201371.","journal-title":"Anal Biochem"},{"key":"3807_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0049-3848(01)00224-9","volume":"102","author":"M Wilmer","year":"2001","unstructured":"Wilmer M, Rudin K, Kolde H, et al. Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency. Thromb Res. 2001;102:81\u201391.","journal-title":"Thromb Res"},{"key":"3807_CR34","first-page":"52","volume":"12","author":"A Ichinose","year":"2022","unstructured":"Ichinose A. Autoimmune acquired coagulation factor XIII\/13 deficiency. Thrombosis Medicine. 2022;12:52\u201360.","journal-title":"Thrombosis Medicine"},{"key":"3807_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1055\/s-0038-1648185","volume":"65","author":"K Fickenscher","year":"1991","unstructured":"Fickenscher K, Aab A, St\u00fcber W. A photometric assay for blood coagulation factor XIII. Thromb Haemost. 1991;65:535\u201340.","journal-title":"Thromb Haemost"},{"key":"3807_CR36","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1172\/JCI106061","volume":"48","author":"L Lorand","year":"1969","unstructured":"Lorand L, Urayama T, De Kiewiet JW, Nossel HL. Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation. J Clin Invest. 1969;48:1054\u201364.","journal-title":"J Clin Invest"},{"key":"3807_CR37","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/0076-6879(70)19065-3","volume":"19","author":"L Lorand","year":"1970","unstructured":"Lorand L, Gotoh T. Fibrinoligase: the fibrin stabilizing factor system. Methods Enzymol. 1970;19:770\u201382.","journal-title":"Methods Enzymol"},{"key":"3807_CR38","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1073\/pnas.75.9.4234","volume":"75","author":"RB Credo","year":"1978","unstructured":"Credo RB, Curtis CG, Lorand L. Ca2+-related regulatory function of fibrinogen. Proc Natl Acad Sci USA. 1978;75:4234\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3807_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0076-6879(81)80029-8","volume":"80 Pt C","author":"L Lorand","year":"1981","unstructured":"Lorand L, Credo RB, Janus TJ. Factor XIII (fibrin-stabilizing factor). Methods Enzymol. 1981;80 Pt C:333\u201341.","journal-title":"Methods Enzymol"},{"key":"3807_CR40","first-page":"1508","volume":"64","author":"M Kadono","year":"2023","unstructured":"Kadono M, Souri M, Shimomura T, et al. Autoimmune acquired coagulation factor XIII\/13 deficiency caused by type Ab anti-FXIII-A autoantibody. Rinsho Ketsueki. 2023;64:1508\u201313.","journal-title":"Rinsho Ketsueki"},{"key":"3807_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ajh.26426","volume":"97","author":"S Shimoyama","year":"2022","unstructured":"Shimoyama S, Kanisawa Y, Ono K, Souri M, Ichinose A. First and fatal case of autoimmune acquired factor XIII\/13 deficiency after COVID-19\/SARS-CoV-2 vaccination. Am J Hematol. 2022;97:243\u20135.","journal-title":"Am J Hematol"},{"key":"3807_CR42","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1055\/a-1863-7265","volume":"122","author":"S Nakamura","year":"2022","unstructured":"Nakamura S, Sugasaki M, Souri M, et al. Autoimmune acquired factor XIII\/13 deficiency after SARS-CoV-2 mRNA vaccination. Thromb Haemost. 2022;122:1837\u201342.","journal-title":"Thromb Haemost"},{"key":"3807_CR43","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/ajh.26685","volume":"97","author":"S Ozaki","year":"2022","unstructured":"Ozaki S, Mizuguchi M, Okamoto Y, et al. Frequent bleeding symptoms associated with autoimmune acquired factor XIII\/13 deficiency due to anti-factor XIII A and B subunit antibodies. Am J Hematol. 2022;97:1497\u2013500.","journal-title":"Am J Hematol"},{"key":"3807_CR44","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/MBC.0000000000001202","volume":"34","author":"M Kaneko","year":"2023","unstructured":"Kaneko M, Ishimaru N, Nakajima T, et al. Management of autoimmune factor XIII deficiency in a frail, elderly patient. Blood Coagul Fibrinolysis. 2023;34:408\u201313.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3807_CR45","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1126\/science.3287615","volume":"240","author":"JA Swets","year":"1988","unstructured":"Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285\u201393.","journal-title":"Science"},{"key":"3807_CR46","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","volume":"10","author":"F Peyvandi","year":"2012","unstructured":"Peyvandi F, Palla R, Menegatti M, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost. 2012;10:615\u201321.","journal-title":"J Thromb Haemost"},{"key":"3807_CR47","first-page":"2300","volume":"55","author":"K Hayakawa","year":"2014","unstructured":"Hayakawa K, Tamura S, Gima H, et al. Successful treatment of chronic disseminated intravascular coagulation using recombinant human soluble thrombomodulin in a dialysis patient with dissecting aortic aneurysm. Rinsho Ketsueki. 2014;55:2300\u20135.","journal-title":"Rinsho Ketsueki"},{"key":"3807_CR48","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12185-015-1754-8","volume":"101","author":"T Kotake","year":"2015","unstructured":"Kotake T, Souri M, Takada K, Kosugi S, Nakata S, Ichinose A. Report of a patient with chronic intractable autoimmune hemorrhaphilia due to anti-factor XIII\/13 antibodies who died of hemorrhage after sustained clinical remission for 3 years. Int J Hematol. 2015;101:598\u2013602.","journal-title":"Int J Hematol"},{"key":"3807_CR49","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.2169\/internalmedicine.54.4791","volume":"54","author":"E Uchida","year":"2015","unstructured":"Uchida E, Watanabe K, Arai R, et al. Autoimmune hemorrhaphilia resulting from autoantibody against the a subunit of factor XIII. Intern Med. 2015;54:2383\u20137.","journal-title":"Intern Med"},{"key":"3807_CR50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000455938","volume":"137","author":"Y Ogawa","year":"2017","unstructured":"Ogawa Y, Yanagisawa K, Souri M, et al. Successful management of a patient with autoimmune hemorrhaphilia due to Anti-Factor XIII\/13 antibodies complicated by pulmonary thromboembolism. Acta Haematol. 2017;137:141\u20137.","journal-title":"Acta Haematol"},{"key":"3807_CR51","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1160\/TH14-09-0745","volume":"113","author":"T Osaki","year":"2015","unstructured":"Osaki T, Sugiyama D, Magari Y, Souri M, Ichinose A. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII\/13. Thromb Haemost. 2015;113:1347\u201356.","journal-title":"Thromb Haemost"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03807-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03807-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03807-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T14:18:17Z","timestamp":1726841897000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03807-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["3807"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03807-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"3 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No authors declared competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}